MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants

MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has bolstered company coffers via the exercise of warrants by investors. In total, the company has brought in roughly $1.5 million in cash from the exercise of warrants.

The exercise of warrants has resulted in approximately 3.2 million new shares being issued by the company, with the warrants having an average exercise price of $0.48 per share. Following the exercise of these warrants, the company has 40.7 million common shares outstanding as of January 13, 2021.

Net proceeds from the exercise of the warrants is to be used by the company to “advance its organic mustard plant-based crop protection technologies,” as well as for general working capital. Commenting on the exercise, CEO Corey Giasson stated, “A portion of the proceeds will be used to accelerate our disruptive pipeline assets, including our ground-breaking field studies in Colombia where we are working to provide a potential solution to combat the banana disease Fusarium wilt TR4.

MustGrow Biologics last traded at $2.10 on the CSE.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Gold is Up 30%, But the Real Bull Market is Only Starting Now! | Adrian Day

Recommended

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Goliath Resources Expands 2025 Drill Program To 60,000 Metres

Related News

MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics...

Wednesday, September 29, 2021, 08:21:37 AM

MustGrow Biologics Closes Financing At Final Figure Of $7.1 Million

MustGrow Biologics (CSE: MGRO) this morning closed off its previously announced private placement financing. The...

Thursday, October 7, 2021, 07:52:23 AM

MustGrow Conducts Successful Proof Of Concept For Mustard Derived Bio-Herbicide

MustGrow Biologics (CSE: MGRO) has successfully completed a proof-of-concept for its proprietary biological non-selective bio-herbicide....

Wednesday, August 12, 2020, 08:47:23 AM

MustGrow Biologics Demonstrates 100% Control Of Panama Disease In Lab Tests

MustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted...

Tuesday, December 1, 2020, 08:31:08 AM

MustGrow Biologics Sees Continued Positive Results From Field Trials For Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has finally seen the results of its initial field trial program...

Wednesday, November 10, 2021, 08:01:52 AM